Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine

0365072 - ÚMG 2012 RIV GR eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Šímová, Jana - Bieblová, Jana - Bubeník, Jan - Reiniš, Milan
Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.
Oncology Reports. Roč. 25, č. 6 (2011), s. 1683-1689. ISSN 1021-335X. E-ISSN 1791-2431
R&D Projects: GA ČR GA301/09/1024; GA ČR GA301/07/1410
Grant - others:EK(XE) EU-FP6-NOE018933
Institutional research plan: CEZ:AV0Z50520514
Keywords : gemcitabine * human papilloma virus * interleukin 12 * lung metastases * cellular vaccines * immunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 1.835, year: 2011

Permanent Link: http://hdl.handle.net/11104/0200408